Upregulated and/or over-activated NADPH oxidase is a major source of oxidative stress and oxidative neuronal damages during neuroinflammation and has been implicated as a therapeutic target for neurodegenerative diseases including AD [58]. The gene discussed is FMO5; the disease is Alzheimer disease.